VIVIAN PEREZ: Open Payments
NPI 1174998033 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,484 in 53 payments from 13 companies in 2025. Trend: 2023 $1,071 · 2024 $639 · 2025 $1,484
Food & beverage: $1,484
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 9 | $383 |
| Janssen Biotech, Inc. | 13 | $351 |
| ABBVIE INC. | 10 | $173 |
| Lilly USA, LLC | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| Ardelyx, Inc. | 4 | $93 |
| GENZYME CORPORATION | 3 | $82 |
| Gilead Sciences, Inc. | 2 | $43 |
| VIVUS LLC | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
Products named: REZDIFFRA, TREMFYA, OMVOH, CREON, IBSRELA, DUPIXENT, EOHILIA, ENTYVIO.
Industry payments across FL — which companies pay providers there.
